𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

✍ Scribed by A. Biete Solà; J. Marruecos Querol; F. A. Calvo Manuel; E. Verger Fransoy; À. Rovirosa Casino; J. J. Grau de Castro; M. de las Heras González; A. Ramos Aguerri; A. Palacios Eito; C. Veiras Candal; Mª. V. Solano López


Book ID
107596210
Publisher
Springer Milan
Year
2007
Tongue
Spanish
Weight
469 KB
Volume
9
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A Phase I/II trial of concurrent docetax
✍ Roy B. Tishler; Charles M. Norris Jr.; A. Dimitrios Colevas; Carolyn C. Lamb; Da 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a Phase I/II study in patients with a poor prognosis who had locally advanced squamous cell carcinoma of the head and neck (SCCHN) and who were treated initially with induction chemotherapy. Patients were treated with weekly docetaxel and concurrent

Combination chemotherapy for advanced sq
✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th

Phase I and initial phase II results fro
✍ David L. Schwartz; R. Bruce Montgomery; Bevan Yueh; Michael Donahue; Yoshimi Anz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract ## BACKGROUND The current Phase I/II study assessed induction docetaxel/carboplatin given weekly for 4 weeks, followed by weekly docetaxel/carboplatin and concomitant boost radiotherapy (CB‐XRT) for locally advanced head and neck squamous cell carcinoma. ## METHODS Twenty patients wi